相关实验视频

Updated: Jan 10, 2026

Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment

Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment

Published on: March 25, 2020

重新连接瘤可见性:免疫体作为抗原处理,微环境压力和免疫识别之间的动态接口

Kangkang Zhao¹, Yunlan Huang², Linlin Chang²

¹Department of 4th Radiotherapy, Jilin Cancer Hospital, Changchun, China.

Frontiers in oncology

|November 26, 2025

概括

瘤免疫,由蛋白酶和抗原处理途径调节,影响癌症对免疫系统的可见性. 了解这些机制和瘤微环境相互作用是开发精确免疫瘤治疗的关键.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
分子生物学分子生物学

背景情况:

瘤免疫组决定了癌细胞对免疫监测的可见性.
免疫组的调节涉及到超越规范路径的复杂抗原处理.

研究的目的:

综合当前关于塑造瘤免疫型的因素的知识.
探索瘤内在重新连接和微环境压力因素的作用.
突出显示翻译后修饰联体作为瘤抗原的独特类别.

主要方法:

关于蛋白质体,免疫蛋白质体,TAP,ERAP和替代加工途径的最新研究的综述和综合.
分析瘤内在因素和微环境压力因素 (低氧,酸度,EMT) 之间的相互作用.
研究翻译后改性联结体及其在抗原呈现中的作用.

主要成果:

免疫蛋白酶作为各种癌症的预后和预测生物标志物,取决于免疫环境.
翻译后改性联结体代表着瘤抗原的独特类别.
瘤免疫皮体调节受蛋白质体,TAP,ERAP和微环境因素的影响.

结论:

需要具有背景意识的治疗策略,包括免疫蛋白质酶调节和PTM导向疫苗.
免疫体是一个动态的接口,为免疫逃脱提供了洞察力,并指导了精确的免疫瘤学.
准免疫体为新型癌症免疫疗法提供了一个有希望的路线图.

关键词:

处理抗原处理.免疫蛋白质组中的免疫蛋白质组.免疫治疗的生物标志物翻译后的修改翻译后的修改瘤免疫皮群 (Immunopeptidome) 是一个针对瘤的免疫组织.

更多相关视频

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors

Published on: June 7, 2018

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model

Published on: April 13, 2015

相关概念视频

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.